nivolumab,ipilimumab
bms
['gastric', 'cm649']
imo the ph2 #moonlight trial conveys the same message as the cm649 trial io+io w/o chemo is definitely not the best option for unselected 1st line #gastric cancer! #esmo22
Medical Oncologist at Hospital Sírio-Libanês Translational Oncology ?? Former fellow @FellowsHsl ???? @ASCO Trainee & Early Career Advisory Group